Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolphin Asset Management is a New York-based investment firm that specializes in private equity and direct investments, with a significant focus on the healthcare and life sciences sectors. Founded by Peter J. Solomon, the firm operates primarily through its Dolphin Direct Equity Partners arm to provide growth capital and strategic guidance to middle-market companies. Their healthcare portfolio historically includes investments in medical devices, healthcare services, and specialized clinical providers. The firm is known for taking an active role in its portfolio companies to drive operational improvements and long-term value creation. While not a drug development company itself, it serves as a key financial catalyst for innovation within the healthcare services and medical technology landscapes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dolphin Asset Management.